Business Description
New Nordic Healthbrands AB
ISIN : SE0001838038
Compare
Compare
Traded in other countries / regions
NNH.SwedenN9X.Germany IPO Date
2024-08-29Description
New Nordic Healthbrands AB develops herbal supplements, herbal remedies, and personal care products to satisfy specific health and beauty needs. The products are sold in North America, Europe, and Asia. Some products sold are Active legs, Active Liver, Apple Cider, Chili Burn, Clear brain, Ear tone, Equazen, Frutin gastro gel, Hair Gro, Hair Volume, Kilo trim, and Melissa Dream. Maximum revenue is generated from the Nordic region.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.22 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.47 | |||||
| Debt-to-EBITDA | -5.03 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.9 | |||||
| Beneish M-Score | -2.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.9 | |||||
| 3-Year FCF Growth Rate | 11.9 | |||||
| 3-Year Book Growth Rate | 0.4 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.53 | |||||
| 9-Day RSI | 52.66 | |||||
| 14-Day RSI | 49.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.57 | |||||
| Quick Ratio | 0.83 | |||||
| Cash Ratio | 0.07 | |||||
| Days Inventory | 199.37 | |||||
| Days Sales Outstanding | 63.27 | |||||
| Days Payable | 155.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 2.74 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.96 | |||||
| Operating Margin % | -2.08 | |||||
| Net Margin % | -2.82 | |||||
| FCF Margin % | -2.23 | |||||
| ROE % | -14.68 | |||||
| ROA % | -6.1 | |||||
| ROIC % | -6.6 | |||||
| ROC (Joel Greenblatt) % | -10.85 | |||||
| ROCE % | -10.63 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 6 | |||||
| PS Ratio | 0.17 | |||||
| PB Ratio | 0.95 | |||||
| Price-to-Tangible-Book | 1.01 | |||||
| EV-to-EBIT | -11.29 | |||||
| EV-to-EBITDA | -14.2 | |||||
| EV-to-Revenue | 0.24 | |||||
| EV-to-FCF | -10.45 | |||||
| Price-to-Projected-FCF | 0.96 | |||||
| Price-to-Median-PS-Value | 0.28 | |||||
| Price-to-Net-Current-Asset-Value | 1.21 | |||||
| Earnings Yield (Greenblatt) % | -8.86 | |||||
| FCF Yield % | -13.21 | |||||
| Forward Rate of Return (Yacktman) % | -9.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
New Nordic Healthbrands AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 48.15 | ||
| EPS (TTM) (€) | -0.22 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 49.12 | ||
| 14-Day ATR (€) | 0.026758 | ||
| 20-Day SMA (€) | 1.251 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 1.22 - 1.53 | ||
| Shares Outstanding (Mil) | 6.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
New Nordic Healthbrands AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
New Nordic Healthbrands AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
New Nordic Healthbrands AB Frequently Asked Questions
What is New Nordic Healthbrands AB(FRA:N9X)'s stock price today?
The current price of FRA:N9X is €1.26. The 52 week high of FRA:N9X is €1.53 and 52 week low is €1.22.
When is next earnings date of New Nordic Healthbrands AB(FRA:N9X)?
The next earnings date of New Nordic Healthbrands AB(FRA:N9X) is 2025-02-28.
Does New Nordic Healthbrands AB(FRA:N9X) pay dividends? If so, how much?
New Nordic Healthbrands AB(FRA:N9X) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers